Overview

Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Status:
Terminated

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

The study is a prospective, multi-centre, observational study designed to assess the long-term effectiveness and safety of alefacept in subjects with moderate to severe chronic plaque psoriasis.

Details

Lead Sponsor:

Astellas Pharma Inc

Collaborator:

Astellas Pharma Canada, Inc.

Treatments:

Alefacept